Major reduction of NKT cells in patients with severe COVID-19 pneumonia

Autor: Miriam Lichtner, Giuseppe La Torre, Parni Nijhawan, Fabio Mengoni, Francesco Cogliati Dezza, Claudio Maria Mastroianni, Valentina Perri, Maria Rosa Ciardi, Claudia D'Agostino, Giulia Savelloni, Patrizia Pasculli, Maria Antonella Zingaropoli
Rok vydání: 2020
Předmět:
Zdroj: Clinical Immunology (Orlando, Fla.)
Clinical Immunology
ISSN: 1521-7035
Popis: Background NK cells seem to be mainly involved in COVID-19 pneumonia. Little is known about NKT cells which represent a bridge between innate and adaptive immunity. Methods We characterized peripheral blood T, NK and NKT cells in 45 patients with COVID-19 pneumonia (COVID-19 subjects) and 19 healthy donors (HDs). According to the severity of the disease, we stratified COVID-19 subjects into severe and non-severe groups. Results Compared to HDs, COVID-19 subjects showed higher percentages of NK CD57+ and CD56dim NK cells and lower percentages of NKT and CD56bright cells. In the severe group we found a significantly lower percentage of NKT cells. In a multiple logistic regression analysis, NKT cell was independently associated with the severity of the disease. Conclusions The low percentage of NKT cells in peripheral blood of COVID-19 subjects and the independent association with the severity of the disease suggests a potential role of this subset.
Graphical abstract Unlabelled Image
Highlights • High percentages of NK CD57+ cells and CD56dimNK cells in COVID-19 subjects • Low percentages of CD56bright and NKT cells in COVID-19 subjects • Severe COVID-19 pneumonia and NKT cell reduction were independently associated
Databáze: OpenAIRE